MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
62 hedge funds and large institutions have $98.5M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $91M → $98.5M (+$7.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
62
Holding in Top 10
2
Calls
$2.38M
Puts
$407K
Top Buyers
| 1 | +$5.58M | |
| 2 | +$1.52M | |
| 3 | +$1.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.21M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.08M |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$985K | |
| 3 | -$873K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$804K |
| 5 |
Jane Street
New York
|
-$459K |